DATA AVAILABILITY STATEMENT
Bristol Myers Squibb will honor legitimate requests for clinical trial data from qualified researchers. Data will be shared with external researchers whose proposed use of the data has been approved. Complete de‐identified patient data sets will be eligible for sharing 2 years after completion of the CheckMate 649 study. Before data are released the researcher(s) must sign a Data Sharing Agreement after which the de‐identified and anonymized datasets can be accessed within a secured portal. Bristol Myers Squibb policy on data sharing may be found at 